Curable composition for use in a high temperature lithography-based photopolymerization process and method of producing crosslinked polymers therefrom
US-2024325117-A1 · Oct 3, 2024 · US
US9676959B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9676959-B2 |
| Application number | US-201414890453-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 23, 2014 |
| Priority date | May 29, 2013 |
| Publication date | Jun 13, 2017 |
| Grant date | Jun 13, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A polymerizable composition solution that has good storage stability and allows a polymerizable compound in the polymerizable composition to be aligned well with no defects after application to a base and removal of a solvent by a drying process and also an optically anisotropic body that includes the solution and has good alignment without any defects. A solution containing a polymerizable composition and an organic solvent, wherein the polymerizable composition contains 90 mass % or more of a polymerizable compound intramolecularly having a 2-methyl-1,4-phenylene group as represented by general formula (1) and an optically anisotropic body including the solution.
Opening claim text (preview).
The invention claimed is: 1. A solution comprising a polymerizable composition and an organic solvent, wherein the polymerizable composition contains 90 mass % or more of at least one polymerizable compound selected from polymerizable compounds represented by general formula (1-1) and general formula (1-2): wherein in formula (1-1) P represents a polymerizable functional group; Sp represents a single bond or a spacer group, wherein the spacer group is an alkylene group having 1 to 18 carbon atoms, wherein the spacer group is optionally substituted with at least one halogen atom or CN, and one CH 2 group or at least two nonadjacent CH 2 groups are optionally each independently substituted with —O—, —S—, —NH—, —N(CH 3 )—, —CO—, —COO—, —SCO—, —COS—, or —C≡C—, as long as oxygen atoms are not directly bonded to each other; when at least two P are present, the at least two P are the same or different; and when at least two Sp are present, the at least two Sp are the same or different, A 1 and A 2 each independently represent a (b) a 1,4-phenylene group (one —CH═ or two or more nonadjacent —CH═ in this group may be substituted with —N═), Z 1 and Z 2 each independently represent a single bond, —COO—, —OCO—, or —C≡C—; and m 1 and n 1 each independently represent 0, 1, 2, 3, or 4, and m 1 +n 1 four or less; when m 1 is 2 to 4 and two or more A 1 and Z 1 are present, two or more A 1 and two or more Z 1 are each the same or different; when n 1 is 2 to 4 and two or more A 2 and Z 2 are present, two or more A 2 and two or more Z 2 are each the same or different, wherein in formula (1-2) P represents a polymerizable functional group; Sp represents a single bond or a spacer group, wherein the spacer group is an alkylene group having 1 to 18 carbon atoms, wherein the spacer group is optionally substituted with at least one halogen atom or CN, and one CH 2 group or at least two nonadjacent CH 2 groups are optionally each independently substituted with —O—, —S—, —NH—, —N(CH 3 )—, —CO—, —COO—, —SCO—, —COS—, or —C≡C—, as long as oxygen atoms are not directly bonded to each other; when at least two P are present, the at least two P are the same or different and when at least two Sp are present, the at least two Sp can be the same or different, A 1 and A 2 each independently represent a group selected from the group consisting of: (a) 1,4-cyclohexylene group (one —CH 2 — or two or more nonadjacent —CH 2 — in this group may be substituted with —O— or —S—); (b) a 1,4-phenylene group (one —CH═ or two or more nonadjacent —CH═ in this group is optionally substituted with —N═), and (c) naphthalene-2,6-diyl group optionally substituted with a alkyl group having 1 carbon atom Z 1 and Z 2 each independently represent a single bond, —COO—, —OCO—, or —C≡C—; where one of R 4 and R 5 represents a hydrogen atom and the other represents a methyl group, R 22 represents a hydrogen atom, a halogeno group, a cyano group, or aalkyl group having 1 to 8 carbon atoms, and one —CH 2 — or two or more nonadjacent —CH 2 — in the alkyl group is optionally each independently substituted with —CH═CH—, —C≡C—, —O—, —CO—, —COO—, or —OCO—, and at least one hydrogen atom in the alkyl group may be substituted with a fluorine atom or a chlorine atom, and m 2 and n 2 each independently represent 0, 1, 2, 3, or 4, and m 2 +n 2 four or less; when m 2 is 2 to 4 and two or more A 1 and Z 1 are present, two or more A 1 and two or more Z 1 are each the same or different when n 2 is 2 to 4 and two or more A 2 and Z 2 are present, two or more A 2 and two or more Z 2 are each the same or different, wherein the polymerizable composition comprises 30 to 90 mass % of the polymerizable compound represented by general formula (1-1). 2. The solution according to claim 1 , wherein the organic solvent is at least one of ketone solvents, ether solvents, ester solvents, and aromatic hydrocarbon solvents. 3. The solution according to claim 1 , further comprising a polymerization initiator. 4. The solution according to claim 1 , further comprising a polymerizable chiral compound. 5. The solution according to claim 1 , further comprising a polymerizable discotic compound. 6. The solution according to claim 1 , further comprising a surfactant. 7. An optically anisotropic body comprising a dried and cured product of the solution according to claim 1 . 8. A retardation film comprising a dried and cured product of the solution according to claim 1 . 9. An optical compensation film comprising a dried and cured product of the solution according to claim 1 . 10. A retardation patterned film comprising a dried and cured product of the solution according to claim 1 . 11. A homogeneously aligned liquid crystal film comprising a dried and cured product of the solution according to claim 1 . 12. A laminated optically anisotropic body having a laminate of a plurality of the optically anisotropic bodies according to claim 7 .
Birefringent or phase retarding elements (G02B5/3008, G02B5/3016 take precedence; systems for polarisation control G02B27/286; manufacturing phase modulating patterns by lithographic processes G03F7/001) · CPC title
and two or more oxygen atoms in the alcohol moiety · CPC title
curable · CPC title
Homopolymers or copolymers of esters (C09D135/06, C09D135/08 take precedence) · CPC title
of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.